ChinaHealthcare and life sciences2025 – ongoingRuijin Hospital
RuiPath pathology foundation model in clinical workflows
Ruijin Hospital and Huawei reported RuiPath use at more than 90 hospitals
Problem
Ruijin Hospital sought to make specialist pathology capabilities available to hospitals with fewer diagnostic resources.
Approach
Ruijin Hospital and Huawei released a clinical pathology model in February 2025 that entered hospital production workflows. RuiPath 2.0 expanded diagnostic coverage in August 2026 and added explanations of image findings. A smaller version supported deployment on ordinary hospital PCs.
Results
Takeaway
The reported hospital count established deployment reach. It did not establish improved patient outcomes.
Categories
- Size
- Large enterprise
- Industry
- Healthcare and life sciences
- Business function
- Production and quality
- Innovation type
- Process innovationProduct and service innovation
- AI technology
- Computer visionGenerative AI
- Adoption
- Partner co-development
- Evidence
- Company's own claim
Sources
Source summaries
Xinhua reported the joint model release and its earlier entry into clinical workflows. It relayed deployment and diagnostic-coverage claims from the launch.
Full details are in the original sources.
